Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant
tumor antigen proteins can be produced on a large scale at relatively low cost and have …

Carcinoembryonic antigen (CEA) is a well‐known tumor antigen that is found in the serum of
patients with various cancers and is correlated with an increased risk of cancer recurrence …

In order to develop immunotherapy strategies that are based on eliciting immune
responsiveness to the self-antigen, human carcinoembryonic antigen (CEA), we examined …

Peripheral T-cell tolerance toward human carcinoembryonic self-antigen (CEA) was broken
in CEA-transgenic C57BL/6J mice by an oral CEA-based DNA vaccine. This vaccine …

Antigen specific cytotoxic T lymphocytes (CTL) are being studied for their potential
immunotherapeutic benefit in the treatment of cancer. Carcinoembryonic antigen (CEA) is an …

Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant
tumor antigen proteins can be produced on a large scale at relatively low cost and have …

The applicability of immunotherapy would be dramatically broadened to a greater number of
recipients if direct “off-the-shelf” products could be engineered to engender functionally …

Identification of relevant targets for cancer therapy is a major goal in cancer research. In this
field, the identification of tumor antigens has opened the possibility of inducing specific anti …

Cancer-testis (CT) antigens represent attractive potential targets for cancer immunotherapy
due to their limited expression in normal somatic tissues and their widespread expression in …